NO167142C - Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.

Info

Publication number: NO167142C
Authority: NO; Norway
Prior art keywords: preparation; heterocyclic derivatives; therapeutic active; analogy procedure; active heterocyclic
Prior art date: 1984-08-22

Application number

NO853293A

Other languages

English (en)

Norwegian (no)

Other versions

NO853293L (no

NO167142B (no

Inventor

Claudio Semeraro

Dino Micheli

Daniele Pieraccioli

Giovanni Gaviraghi

Allan David Borthwick

Original Assignee

Glaxo Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-08-22

Filing date

1985-08-21

Publication date

1991-10-09

1984-08-22 Priority claimed from IT22383/84A external-priority patent/IT1175620B/it

1985-07-05 Priority claimed from IT21460/85A external-priority patent/IT1187678B/it

1985-08-21 Application filed by Glaxo Spa filed Critical Glaxo Spa

1986-02-24 Publication of NO853293L publication Critical patent/NO853293L/no

1991-07-01 Publication of NO167142B publication Critical patent/NO167142B/no

1991-10-09 Publication of NO167142C publication Critical patent/NO167142C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
- C03B2205/00—Fibre drawing or extruding details
- C03B2205/44—Monotoring or regulating the preform feed rate

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Hydrogenated Pyridines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO853293A 1984-08-22 1985-08-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. NO167142C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT22383/84A IT1175620B (it)	1984-08-22	1984-08-22	Derivati piridinici
IT21460/85A IT1187678B (it)	1985-07-05	1985-07-05	Procedimento di preparazione di derivati eterociclici

Publications (3)

Publication Number	Publication Date
NO853293L NO853293L (no)	1986-02-24
NO167142B NO167142B (no)	1991-07-01
NO167142C true NO167142C (no)	1991-10-09

Family

ID=26327905

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO853293A NO167142C (no)	1984-08-22	1985-08-21	Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO1999007C NO1999007I1 (no)	1984-08-22	1999-04-23	Lacidipin

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO1999007C NO1999007I1 (no)	1984-08-22	1999-04-23	Lacidipin

Country Status (33)

Country	Link
US (2)	US4801599A (fi)
JP (2)	JPS6193162A (fi)
KR (1)	KR920004482B1 (fi)
AT (1)	AT394042B (fi)
AU (1)	AU578724B2 (fi)
BE (1)	BE903103A (fi)
BG (1)	BG60409B2 (fi)
CA (1)	CA1268180A (fi)
CH (1)	CH666684A5 (fi)
CS (1)	CS403091A3 (fi)
CY (1)	CY1494A (fi)
DE (1)	DE3529997C2 (fi)
DK (1)	DK165949C (fi)
ES (5)	ES8703839A1 (fi)
FI (1)	FI81568C (fi)
FR (1)	FR2569402B1 (fi)
GB (1)	GB2164336B (fi)
GR (1)	GR852016B (fi)
HK (1)	HK52990A (fi)
HU (1)	HU196754B (fi)
IE (1)	IE58486B1 (fi)
LU (2)	LU86047A1 (fi)
MX (1)	MX159974A (fi)
NL (2)	NL193065C (fi)
NO (2)	NO167142C (fi)
NZ (1)	NZ212895A (fi)
PH (1)	PH22014A (fi)
PT (1)	PT81000B (fi)
SA (1)	SA91120277B1 (fi)
SE (1)	SE459920B (fi)
SG (1)	SG40889G (fi)
SK (1)	SK278327B6 (fi)
ZW (1)	ZW13185A1 (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ212895A (en) *	1984-08-22	1988-07-28	Glaxo Spa	1,4-dihydropyridine derivatives and pharmaceutical compositions
DE3628215C2 (de) *	1985-08-21	1996-09-19	Glaxo Spa	1,4-Dihydro-2-alkylenamino-3,5-dicarbonester-4-(2-propenyl)-phenyl-pyridine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung
DE3675747D1 (de) *	1985-08-21	1991-01-03	Glaxo Spa	1,4-dihydropyridinverbindungen und ihre herstellung und pharmazeutische formulierung.
IT1204460B (it) *	1986-02-20	1989-03-01	Glaxo Spa	Derivati eterociclici
IT1204462B (it) *	1986-02-20	1989-03-01	Glaxo Spa	Derivati eterociclici
IT1204461B (it) *	1986-02-20	1989-03-01	Glaxo Spa	Derivati eterociclici
IT1233370B (it) *	1988-11-21	1992-03-27	Glaxo Spa	Procedimento di preparazione di derivati diidropipiridinici utili nel trattamento di disturbi cardiovascolari
DE69030982T2 (de)	1989-04-27	1997-11-13	Canon Kk	Optisches Aufzeichnungsmedium und Verfahren zu seiner Herstellung
US5196529A (en) *	1990-10-09	1993-03-23	Merck & Co., Inc.	2-phenanthrenyl carbapenem intermediates
US5177202A (en) *	1990-10-09	1993-01-05	Merck & Co., Inc.	2-phenanthrenyl-carbapenems
US5132422A (en) *	1990-10-09	1992-07-21	Merck & Co., Inc.	2-naphthyl-carbapenem intermediates
US5132421A (en) *	1990-10-09	1992-07-21	Merck & Co., Inc.	2-naphthyl-carbapenem intermediates
US5144028A (en) *	1990-10-09	1992-09-01	Merck & Co., Inc.	2-(9-fluorenonyl)-carbapenem intermediates
US5356889A (en) *	1990-08-01	1994-10-18	Merck & Co., Inc.	2-(9-fluorenonyl)-carbapenem intermediates
US5208329A (en) *	1990-10-09	1993-05-04	Merck & Co., Inc.	2-biphenyl carbapenem intermediates
IT1244728B (it) *	1991-02-13	1994-08-08	Glaxo Spa	Impiego medicamentoso di derivati diidropiridinici
TW483763B (en) *	1994-09-02	2002-04-21	Astra Ab	Pharmaceutical composition comprising of ramipril and dihydropyridine compound
AU1042199A (en) *	1998-11-06	2000-05-29	Boehringer Ingelheim International Gmbh	Antihypertensive medicaments containing lacidipine and telmisartan
OA12905A (en)	2002-08-19	2006-10-13	Pfizer Prod Inc	Combination therapy for hyperproliferative diseases.
EA009646B1 (ru) *	2003-05-30	2008-02-28	Рэнбакси Лабораториз Лтд.	Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa
US20050037063A1 (en) *	2003-07-21	2005-02-17	Bolton Anthony E.	Combined therapies
MX2007000979A (es) *	2004-07-26	2007-07-11	Cotherix Inc	Tratamiento de la hipertension pulmonar por iloprost inhalado con una formulacion microparticulada.
EP1868577A4 (en)	2005-04-15	2009-12-09	Reddys Lab Inc Dr	Lacidipine PARTICLE
US20070043088A1 (en) *	2005-08-16	2007-02-22	Eswaraiah Sajja	Process for preparing lacidipine
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
WO2007050783A2 (en)	2005-10-26	2007-05-03	Asahi Kasei Pharma Corporation	Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP2351569B1 (en)	2005-10-26	2012-08-22	Asahi Kasei Pharma Corporation	Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP1948599A1 (en) *	2005-11-08	2008-07-30	Ranbaxy Laboratories Limited	Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
US7919506B2 (en)	2006-03-10	2011-04-05	Pfizer Inc.	Dibenzyl amine compounds and derivatives
TW200744583A (en) *	2006-03-14	2007-12-16	Ranbaxy Lab Ltd	Statin stabilizing dosage formulations
CN101494980A (zh) *	2006-07-14	2009-07-29	兰贝克赛实验室有限公司	HMG-CoA还原酶抑制剂的多晶型形式及其应用
US20080089947A1 (en) *	2006-08-18	2008-04-17	Knox Clayton D	Calcium Influx Inhibitors in the Treatment of Ischemia
WO2008070496A2 (en)	2006-12-01	2008-06-12	Bristol-Myers Squibb Company	N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2012037665A1 (en)	2010-09-24	2012-03-29	Oral Delivery Technology Ltd.	Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
PL2705839T3 (pl)	2012-09-10	2018-07-31	Rivopharm Sa	Farmaceutyczna kompozycja zawierająca lacydypinę i proces przygotowania
RU2618628C1 (ru)	2013-04-17	2017-05-05	Пфайзер Инк.	Производные N-пиперидин-3-илбензамида для лечения сердечно-сосудистых заболеваний
WO2016055901A1 (en)	2014-10-08	2016-04-14	Pfizer Inc.	Substituted amide compounds
CA3125765A1 (en)	2019-01-18	2020-07-23	Astrazeneca Ab	Pcsk9 inhibitors and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3455945A (en) *	1967-06-07	1969-07-15	Smithkline Corp	4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines
DE2228363A1 (de) *	1972-06-10	1974-01-03	Bayer Ag	1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1409865A (en) *	1973-02-13	1975-10-15	Science Union & Cie	Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
US4307103A (en) *	1978-09-08	1981-12-22	Fujisawa Pharmaceutical Co., Ltd.	Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
DE3018259A1 (de) *	1980-05-13	1981-11-19	Bayer Ag, 5090 Leverkusen	1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
NZ201395A (en) *	1981-07-30	1987-02-20	Bayer Ag	Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) *	1982-03-05	1983-09-08	Bayer Ag, 5090 Leverkusen	Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
NZ212895A (en) *	1984-08-22	1988-07-28	Glaxo Spa	1,4-dihydropyridine derivatives and pharmaceutical compositions

1985
- 1985-07-29 NZ NZ212895A patent/NZ212895A/xx unknown
- 1985-08-20 GR GR852016A patent/GR852016B/el unknown
- 1985-08-20 NL NL8502296A patent/NL193065C/nl not_active IP Right Cessation
- 1985-08-20 ZW ZW131/85A patent/ZW13185A1/xx unknown
- 1985-08-20 SE SE8503888A patent/SE459920B/sv not_active IP Right Cessation
- 1985-08-20 DK DK378085A patent/DK165949C/da not_active IP Right Cessation
- 1985-08-20 US US06/767,593 patent/US4801599A/en not_active Expired - Lifetime
- 1985-08-21 MX MX206376A patent/MX159974A/es unknown
- 1985-08-21 FI FI853206A patent/FI81568C/fi not_active IP Right Cessation
- 1985-08-21 NO NO853293A patent/NO167142C/no not_active IP Right Cessation
- 1985-08-21 LU LU86047A patent/LU86047A1/fr active Protection Beyond IP Right Term
- 1985-08-21 CH CH3593/85A patent/CH666684A5/de not_active IP Right Cessation
- 1985-08-21 LU LU88267C patent/LU88267I2/xx unknown
- 1985-08-21 CY CY1494A patent/CY1494A/xx unknown
- 1985-08-21 ES ES546324A patent/ES8703839A1/es not_active Expired
- 1985-08-21 JP JP60181934A patent/JPS6193162A/ja active Granted
- 1985-08-21 IE IE205485A patent/IE58486B1/en not_active IP Right Cessation
- 1985-08-21 GB GB08520924A patent/GB2164336B/en not_active Expired
- 1985-08-22 PT PT81000A patent/PT81000B/pt unknown
- 1985-08-22 AU AU46576/85A patent/AU578724B2/en not_active Expired
- 1985-08-22 FR FR8512631A patent/FR2569402B1/fr not_active Expired
- 1985-08-22 BE BE0/215493A patent/BE903103A/fr not_active IP Right Cessation
- 1985-08-22 KR KR1019850006044A patent/KR920004482B1/ko not_active IP Right Cessation
- 1985-08-22 AT AT0245485A patent/AT394042B/de not_active IP Right Cessation
- 1985-08-22 CA CA000489261A patent/CA1268180A/en not_active Expired - Lifetime
- 1985-08-22 PH PH32680A patent/PH22014A/en unknown
- 1985-08-22 DE DE3529997A patent/DE3529997C2/de not_active Expired - Lifetime
- 1985-08-22 HU HU853202A patent/HU196754B/hu unknown
1986
- 1986-02-14 ES ES552049A patent/ES8802497A1/es not_active Expired
- 1986-02-14 ES ES552048A patent/ES8707931A1/es not_active Expired
- 1986-02-14 ES ES552051A patent/ES8707932A1/es not_active Expired
- 1986-02-14 ES ES552050A patent/ES8707930A1/es not_active Expired
1988
- 1988-07-27 JP JP63185661A patent/JPH0686430B2/ja not_active Expired - Lifetime
1989
- 1989-01-23 US US07/300,022 patent/US5011848A/en not_active Expired - Lifetime
- 1989-07-06 SG SG40889A patent/SG40889G/en unknown
1990
- 1990-07-12 HK HK529/90A patent/HK52990A/xx not_active IP Right Cessation
1991
- 1991-12-16 SA SA91120277A patent/SA91120277B1/ar unknown
- 1991-12-23 SK SK4030-91A patent/SK278327B6/sk unknown
- 1991-12-23 CS CS914030A patent/CS403091A3/cs unknown
1993
- 1993-08-20 BG BG098061A patent/BG60409B2/bg unknown
1998
- 1998-11-27 NL NL980037C patent/NL980037I2/nl unknown
1999
- 1999-04-23 NO NO1999007C patent/NO1999007I1/no unknown

Also Published As

Publication number	Publication date
DK378085D0 (da)	1985-08-20
ZW13185A1 (en)	1986-03-19
FI81568C (fi)	1990-11-12
HUT40625A (en)	1987-01-28
US4801599A (en)	1989-01-31
IE852054L (en)	1986-02-22
ES552051A0 (es)	1987-09-01
IE58486B1 (en)	1993-09-22
JPH0686430B2 (ja)	1994-11-02
CS403091A3 (en)	1992-06-17
NL193065B (nl)	1998-05-06
ES8707932A1 (es)	1987-09-01
GB2164336A (en)	1986-03-19
BE903103A (fr)	1986-02-24
FI853206L (fi)	1986-02-23
KR920004482B1 (ko)	1992-06-05
ES8703839A1 (es)	1987-03-01
HK52990A (en)	1990-07-20
JPH0550506B2 (fi)	1993-07-29
CY1494A (en)	1990-02-16
DK165949B (da)	1993-02-15
FR2569402B1 (fr)	1989-09-22
SE459920B (sv)	1989-08-21
US5011848A (en)	1991-04-30
PT81000A (en)	1985-09-01
PH22014A (en)	1988-05-02
PT81000B (pt)	1988-03-03
SG40889G (en)	1989-12-22
FR2569402A1 (fr)	1986-02-28
NO1999007I1 (no)	1999-04-23
DE3529997A1 (de)	1986-03-06
AU4657685A (en)	1986-02-27
ES8707930A1 (es)	1987-09-01
ES8802497A1 (es)	1988-07-01
NL980037I1 (nl)	1999-02-01
NL193065C (nl)	1998-09-08
SA91120277B1 (ar)	2006-05-15
ES8707931A1 (es)	1987-09-01
SE8503888D0 (sv)	1985-08-20
DE3529997C2 (de)	1996-01-18
MX159974A (es)	1989-10-17
CA1268180A (en)	1990-04-24
SK278327B6 (en)	1996-11-06
AT394042B (de)	1992-01-27
CH666684A5 (de)	1988-08-15
SE8503888L (sv)	1986-02-23
DK165949C (da)	1993-07-05
FI81568B (fi)	1990-07-31
DK378085A (da)	1986-02-23
JPS6193162A (ja)	1986-05-12
AU578724B2 (en)	1988-11-03
FI853206A0 (fi)	1985-08-21
JPS6479152A (en)	1989-03-24
GB8520924D0 (en)	1985-09-25
NL980037I2 (nl)	1999-03-01
GR852016B (fi)	1985-12-19
NO853293L (no)	1986-02-24
LU88267I2 (fi)	1994-02-03
NZ212895A (en)	1988-07-28
HU196754B (en)	1989-01-30
KR870002073A (ko)	1987-03-28
ATA245485A (de)	1991-07-15
NL8502296A (nl)	1986-03-17
NO167142B (no)	1991-07-01
BG60409B2 (bg)	1995-02-28
ES552049A0 (es)	1988-07-01
ES546324A0 (es)	1987-03-01
ES552048A0 (es)	1987-09-01
LU86047A1 (fr)	1986-02-28
ES552050A0 (es)	1987-09-01
GB2164336B (en)	1988-06-08

Publication	Publication Date	Title
NO167142C (no)	1991-10-09	Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO895086L (no)	1990-06-25	Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
NO163406C (no)	1990-05-23	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO853046L (no)	1986-02-03	Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO862477D0 (no)	1986-06-20	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO167384C (no)	1991-10-30	Analogifremgangsmaate for fremstilling av terapeutisk aktive n-aralkylpiperidinmethanolderivater.
NO162764C (no)	1990-02-14	Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.
NO162514C (no)	1990-01-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater.
NO164097C (no)	1990-08-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO159089C (no)	1988-11-30	Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO165239C (no)	1991-01-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO171638C (no)	1993-04-14	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater
NO165192C (no)	1991-01-09	Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO152129C (no)	1985-08-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO871588L (no)	1987-10-16	Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO168355C (no)	1992-02-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO161562C (no)	1989-08-30	Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO164169C (no)	1990-09-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzothiazinderivater.
NO164897C (no)	1990-11-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO158941C (no)	1988-11-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO161559C (no)	1989-08-30	Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO160079C (no)	1989-03-08	Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO161738C (no)	1989-09-20	Analogifremgangsm te for fremstilling av terapeutisk aktive imidazolinderivater.
NO158739C (no)	1988-10-26	Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO161313C (no)	1989-08-02	Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.

Legal Events

Date	Code	Title	Description
2005-09-12	MK1K	Patent expired